Article

Insurers Forcing Patients to Pay More for Costly Specialty Drugs

prescription drugs

cancer

r

heumatoid arthritis

Thousands of patients in California and across the nation who take expensive every month for , and other ailments are facing sticker shock at the pharmacy.

Aetna

Until recently, most of these patients typically paid modest co-pays for the advanced drugs. But increasingly, Anthem Blue Cross, and other insurers are shifting more prescriptions to a new category requiring patients to shoulder a larger share of the drug's cost.

Read the full story: http://hcp.lv/KXEKBf

Source: Los Angeles Times

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Senator Vincent Polistina (R, New Jersey)
Jeffrey Fitzgerald, JD
CK Wang, MD, COTA
Eric Lander, MD
Eric Lander, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo